Extracorporeal circulation: Complications' prevention and management;Circulacao extracorporea: Prevencao e manuseio de complicacoes

Revista Brasileira de Anestesiologia

Volumn 50, Issue 6, 2000, Pages 464-469

  Auler J O C , Jr ^a   Chiaroni, S ^a  

^a NONE   (Brazil)

Author keywords

Cardiac: extracorporeal circulation; Surgery

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; ENDOTOXIN; GLUCOCORTICOID; HEPARIN; METHYLPREDNISOLONE;

ARTERITIS; ARTERY DISSECTION; ARTERY EMBOLISM; CANNULA; EXTRACORPOREAL CIRCULATION; HEMOFILTRATION; HUMAN; HYPOTHERMIA; INFLAMMATION; REVIEW; TREATMENT INDICATION; VASCULAR ACCESS; VASCULAR ENDOTHELIUM;

EID: 0033773784     PISSN: 00347094     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Artificial maintenance of circulation during experimental occlusion of pulmonary artery
2. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins
3. Gas exchange: Bubble and membrane oxygenators
4. Two membrane oxygenators and a bubbler: A clinical comparison
5. Complement activation during cardiopulmonary bypass
6. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators
7. Accidental hyperperfusion of the left carotid artery during CPB
8. Unilateral cold neck. A new sign of misplacement of the aortic cannula during cardiopulmonary bypass
9. Recognition and management of ascending aortic dissection complicating cardiac surgical operations
10. Massive air embolism during cardiopulmonary bypass: Causes, prevention and management
11. Case 6 - 1991: A 58-yearold man had a massive air embolism during cardiopulmonary bypass [clinical conference]
12. Hyperbaric treatment of cerebral air embolism sustained during an open heart surgical procedure
13. Inflammatory response to cardiopulmonary bypass
14. Bradykinin, plasma protein fraction and hypotension
15. Changes in serum complement and immunoglobulins following cardiopulmonary bypass
16. Complement and the damaging effects of cardiopulmonary bypass
17. Complement activation during major operations without cardiopulmonary bypass
18. Endothelial cell injury in cardiovascular surgery: The systemic inflammatory response
19. Membrane proteins involved in phagocyte adherence to endothelium
20. Neutrophil-mediated pulmonary injury in a canine model of cardiopulmonary bypass: Evidence for a CD18-dependent mechanism
21. Inhibition of neutrophil adherence improves post-ischemic ventricular performance of the neonatal heart
22. Release of vasoactive substances during cardiopulmonary bypass
23. Nitric oxide formation during cardiopulmonary bypass
24. Role of I-arginine-nitric oxide pathway in myocardial reoxygenation injury
25. Calcium-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass
26. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass
27. Evaluation of the role of polymorphonuclear leukocytes on contractile function in myocardial reperfusion injury: Evidence for plasma-mediated leukocyte activation
28. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic and pharmacological considerations
29. Systemic inflammation present in patients undergoing CABG without extracorporeal circulation
30. Organ dysfunction and cardiopulmonary bypass: The role of complement and complement regulatory proteins
31. Neutrophil mediated acute lung injury after extracorporeal circulation
32. Heparin-coated bypass circuits reduce pulmonary injury
33. Can selective digestive decontamination avoid the endotoxemia, and cytokine activation promoted by cardiopulmonary bypass?
34. Effects of glucocorticoids in patients undergoing coronary artery bypass surgery
35. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery
36. Circulating adhesion molecules in cardiac operations: Influence of high dose aprotinin
37. The efficacy and safety of aprotinin use in cardiac surgery
38. Why cardiopulmonary bypass makes patient sick: Strategies to control the blood-synthetic surface interface
39. Tissue factor pathway inhibitor and the current concept of blood coagulation
40. Hemostatic endothelial interactions: A potential anticoagulant role of the endothelium in the pulmonary circulation during cardiac surgery
41. Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions?
42. Ultrafiltration and modified ultrafiltration in pediatric open heart operations
43. Hemofiltration during cardiopulmonary bypass in pediatric-cardiac surgery